Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: On Demand Treatment of Reflux Disease [Phase 4]
Phase 4 clinical trial evaluating an on-demand treatment for gastroesophageal reflux disease has completed.
-
FDA approval · 2011-07-31FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for nizatidine from Epic Pharma, LLC (ANDA 076178). This marks approval of a supplemental update for…
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: The Effect of Lansoprazole in Combination With Ecabet Sodium for Gastroesophageal Reflux Disease [NA]
A completed clinical trial evaluating the combination of lansoprazole and ecabet sodium for gastroesophageal reflux disease.
-
FDA approval · 2011-07-25FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
FDA approved a supplemental application for ZEGERID OTC from Riley Consumer Care LLC to update/expand its OTC labeling for the omeprazole so…
-
FDA approval · 2011-07-22FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for PRILOSEC OTC (omeprazole magnesium) from The Procter & Gamble Manufacturing Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression [NA]
A completed clinical trial reported improvement in bronchial asthma symptoms in patients with gastroesophageal reflux disease following acid…
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease
A completed epidemiological study sponsored by AstraZeneca describes symptom control and the impact of gastroesophageal reflux disease. The …
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) [Phase 2]
A Phase 2 trial evaluating PF-00885706 for relief of GERD symptoms was terminated, with a report on its efficacy and safety observations.
-
CLINICAL_TRIALS trial_result · 2011-07-07Clinical Trial Update: Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - [Phase 3]
A Phase 3 verification study comparing lafutidine to famotidine for mild reflux esophagitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo
Completed clinical trial comparing Endo-Flip and Bravo methods for assessing gastroesophageal reflux.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: The Efficacy of i-Scan for Detecting Reflux Esophagitis [NA]
The completed trial evaluated the efficacy of i-Scan endoscopy for detecting reflux esophagitis in patients with gastroesophageal reflux dis…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Coordination Versus Pressure in Oesophageal Peristalsis
A completed clinical trial update on a study of coordination versus pressure in esophageal peristalsis related to gastroesophageal reflux.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. [Phase 3]
A Phase 3 trial evaluated whether twice-daily rabeprazole improves asthma control in subjects with asthma, with GERD as a co-occurring condi…
-
FDA approval · 2011-06-20FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
CLINICAL_TRIALS research · 2011-06-20Clinical Trial Update: Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms [Phase 2]
Phase 2 study validating patient-reported outcome measures for assessing gastroesophageal reflux disease symptoms. The study, sponsored by A…
-
FDA label_change · 2011-06-17FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Dexilant (dexlansoprazole) submitted by Takeda, resulting in changes to the drug’s labeling.
-
FDA approval · 2011-06-16FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
FDA approved a supplemental application for PRILOSEC OTC (omeprazole magnesium) by The Procter & Gamble Manufacturing Company.
-
CLINICAL_TRIALS trial_result · 2011-06-14Clinical Trial Update: A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience [Phase 2]
A Phase 2 study evaluating four doses of AZD3355 to estimate its effect on reflux episodes in patients with Gastroesophageal Reflux Disease;…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: TLESR-impedance Study in Patients [Phase 2]
Phase 2 trial results update for a TLESR-impedance study in patients with gastroesophageal reflux disease.
-
FDA approval · 2011-06-07FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize the intravenous formulation of Protonix (pantoprazole sodium) from Wyeth Pharmaceut…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: The Utility of Nexium in Chronic Cough and Reflux Disease [Phase 4]
A Phase 4 study assessed the utility of esomeprazole (Nexium) for chronic cough and gastroesophageal reflux disease; the trial is completed …
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Structure and Function of the Gastro-esophageal Junction [NA]
A completed clinical trial at the University of Zurich examined the structure and function of the gastroesophageal junction in gastroesophag…
-
FDA approval · 2011-06-01FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add a Solutab formulation, submitted by Takeda Pharmaceut…
-
FDA label_change · 2011-05-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth/Pfizer to update the product labeling.
-
FDA approval · 2011-05-20FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add the intravenous formulation of PROTONIX (pantoprazole sodium) from Wyeth Pharmaceuticals …